Belgium's Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the year 2022-2030 mainly due to the increasing demand for patient-centric care and individualized treatment option in Belgium. The Belgium Patient Support Programs (PSP) market is segmented by functionality outlook, therapeutic outlook, application outlook, and end user. Some of the major PSP operators in the Belgium Patient Support Programs (PSP) market are Novellas Healthcare, Ashfield Engage, and Remedus.
Belgium's Patient Support Programs (PSP) market size is at around $xx Bn in 2022 and is projected to reach $xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period. With a health budget of 10.7% of GDP in 2019, Belgium ranks among the top ten EU nations in terms of health spending. Belgians have overall good health and a long life expectancy. This is partially attributable to the population's easy access to a wide range of high-quality health services.
A $34.33 Bn health budget for 2022 was authorized by the Belgian federal government. This is a rise of $1.50 Bn from the budget for 2021. The overall social security budget in Belgium includes a number of social welfare initiatives in addition to the health budget. With a total of $19.46 Bn set aside, hospitals receive the majority of the funding from the health budget. Pharmaceutical expenditure, which includes the price of medications and vaccines, is included in the health budget at $5.45 Bn. The health budget allocates $235.25 Mn for initiatives aimed at preventing disease and promoting health, with the goal of enhancing public health and lowering healthcare expenses. Overall, Belgium's health budget for 2022 reflects the country's commitment to delivering high-quality healthcare to its citizens as well as investing in programs and services that encourage better health outcomes and a more efficient healthcare system.
PSPs are created to offer treatment-focused help to patients who are given a medical product on prescription. PSPs are primarily created in Belgium by pharmaceutical firms with the assistance and knowledge of medical specialists. In Belgium, there are a number of disease-specific PSPs that are intended to offer assistance and resources to patients with particular medical conditions like cancer, diabetes, and cardiovascular disease. These initiatives might offer training, resources for self-management, and access to support networks. Telehealth programs, which link patients with healthcare providers and tools using digital technologies, are growing in popularity in Belgium. These programs might provide access to educational methods, remote monitoring, and virtual consultations.
Market Growth Drivers
In the Belgian healthcare system, there is a growing trend toward patient-centered care, which emphasizes delivering care that is tailored to the needs and preferences of individual patients. PSPs are a crucial component of this strategy because they offer patients individualized assistance and resources, which stimulates the Belgium PSP market growth.
PSP delivery in Belgium is not currently standardized. This may make it challenging for people to get access to the programs they require and may reduce the programs’ efficacy. Despite evidence that PSPs can improve patient outcomes, Belgium's healthcare practitioners have only recently begun to use them. This may be caused by a number of things, such as a lack of funding or program implementation expertise. These factors are responsible for impeding the Belgium PSP market growth.
Major Patient Support Programs in Belgium
|Patient Support Programs||Focus Area||Pharma Sponsor|
|FibriCoach||Atrial Fibrillation||Bristol Myers Squibb|
|Lysomed||Lysosomal storage diseases||Sanofi|
|Abbvie Care Program||Chronic Inflammatory Diseases||Abbvie|
|Rheumatoid Arthritis LIGA vzw||Rheumatoid Arthritis||Pfizer|
|Crohn & Colitis ulcerosa Vereniging vzw (Crohn's & Ulcerative Colitis Association vzw)||Chronic Inflammatory Bowel Disease||Pfizer|
|UCB Cares||Treatment Guidance||UCB|
|MyRealWorld MG||Myasthenia Gravis||Argenx|
|'Because there is more to do'||Patient feedback forum||Bristol Myers Squibb|
In Belgium, PSPs are mainly developed by pharmaceutical companies and developed with the support and expertise of healthcare professionals. The Federal Agency for Medicines and Health Products (FAMHP) registered an increase in the use of Patient Support programs (PSPs) in Belgium. According to FAMHP, while setting up a PSP, there should be no direct contact between the pharma company and the patient, and the PSP should thus be implemented via the patients’ healthcare professional. The PSP should not constitute an inducement for healthcare professionals to recommend, prescribe, purchase, sell, supply, or administer medicinal products.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
126.96.36.199 Product Applications and Services
188.8.131.52 Recent Developments
184.108.40.206 Partnerships Ecosystem
220.127.116.11 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Functionality Outlook
By Therapeutic Area Outlook
By Application Outlook
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses